BS EN ISO 80601-2-85:2021
$215.11
Medical electrical equipment – Particular requirements for the basic safety and essential performance of cerebral tissue oximeter equipment
Published By | Publication Date | Number of Pages |
BSI | 2021 | 118 |
Clause 1 of the general standard applies, except as follows.
NOTE The general standard is IEC 60601‑1:2005+AMD1:2012+AMD2:2020.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
5 | Contents Page |
8 | Foreword |
9 | Introduction |
11 | 201.1 Scope, object and related standards 201.1.1 * Scope |
12 | 201.1.2 Object 201.1.3 Collateral standards |
13 | 201.1.4 Particular standards |
14 | 201.2 Normative references |
15 | 201.3 Terms and definitions |
20 | 201.4 General requirements |
21 | 201.4.3.101 * Additional requirements for essential performance 201.4.102 Additional requirements for acceptance criteria 201.4.103 Additional requirements for cerebral tissue oximeter equipment, parts and accessories |
22 | 201.5 General requirements for testing of ME equipment 201.6 Classification of ME equipment and ME systems 201.7 ME equipment identification, marking and documents 201.7.1.101 Information to be supplied by the manufacturer 201.7.2.3 Consult accompanying documents 201.7.2.9.101 IP classification |
23 | 201.7.2.101 Additional requirements for marking on the outside of ME equipment parts 201.7.4.3 Units of measurement 201.7.9.2 Instructions for use 201.7.9.2.1.101 Additional general requirements |
25 | 201.7.9.2.2.101 Additional requirements for warnings and safety notices 201.7.9.2.9.101 Additional requirements for operating instructions 201.7.9.2.14.101 Additional requirements for accessories, supplementary equipment, used material |
26 | 201.7.9.3.1.101 * Additional general requirements 201.8 Protection against electrical hazards from ME equipment 201.8.3.101 Additional requirements for classification of applied parts 201.8.5.5.1.101 Defibrillation protection 201.8.7.4.7.101 Additional requirements for measurement of the patient leakage current |
27 | 201.9 Protection against mechanical hazards of ME equipment and ME systems 201.10 Protection against unwanted and excessive radiation hazards 201.10.4 Lasers 201.11 Protection against excessive temperatures and other hazards 201.11.1.2.2 Applied parts not intended to supply heat to a patient |
28 | 201.11.6.5.101 * Additional requirements for ingress of water or particulate matter into the ME equipment or ME system 201.11.6.7 Sterilization of ME equipment or ME system 201.11.8.101 Additional requirements for interruption of the power supply/supply mains to ME equipment 201.11.8.101.1 Technical alarm condition for power supply failure |
29 | 201.11.8.101.2 Settings and data storage following short interruptions or automatic switchover 201.11.8.101.3 Operation following long interruptions 201.12 Accuracy of controls and instruments and protection against hazardous outputs 201.12.1.101 * StO2 accuracy of cerebral tissue oximeter equipment 201.12.1.101.1 * Specification |
31 | 201.12.1.101.2 * Data collection for determination of StO2 accuracy |
32 | 201.12.1.101.3 * Data analysis for determination of StO2 accuracy |
33 | 201.12.1.101.4 Characteristics of the study used for determination of StO2 accuracy 201.12.4 Protection against hazardous output 201.12.4.101 * Data update period 201.12.4.102 * Signal inadequacy |
34 | 201.13 Hazardous situations and fault conditions for ME equipment 201.13.101 Detection of probe faults and probe cable extender faults 201.14 Programmable electrical medical systems (PEMS) 201.15 Construction of ME equipment |
35 | 201.15.3.5.101 * Additional requirements for rough handling 201.15.3.5.101.1 * Shock and vibration (robustness) |
36 | 201.15.3.5.101.2 * Shock and vibration for a transit-operable cerebral tissue oximeter during operation |
37 | 201.15.101 Mode of operation 201.16 ME systems 201.17 Electromagnetic compatibility of ME equipment and ME systems 201.101 * Cerebral tissue oximeter probes and probe cable extenders 201.101.1 General |
38 | 201.101.2 Labelling 201.102 Functional connection 201.102.1 General 201.102.2 * Connection to an electronic health record or integrated clinical environment 201.102.3 Connection to a distributed alarm system |
39 | 202 Electromagnetic disturbances — Requirements and tests 202.4.3.1 Configurations 202.5.2.2.1 Requirements applicable to all ME equipment and ME systems 202.8.1.101 Additional general requirements 202.8.2 Patient physiological simulation |
40 | 206 Usability 208 General requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical systems 208.6.1.2.101 * Additional requirements for alarm condition priority |
41 | 208.6.5.4.101 * Additional requirements for default alarm preset 208.6.8.5.101 Additional requirements for alarm signal inactivation states, indication and access 211 Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment 212 Requirements for medical electrical equipment and medical electrical systems used in the emergency medical services environment |
42 | Annex C (informative) Guide to marking and labelling requirements for ME equipment and ME systems 201.C.1 Marking on the outside of ME equipment, ME systems or their parts 201.C.2 Accompanying documents, general |
43 | 201.C.3 Accompanying documents, instructions for use |
45 | 201.C.4 Accompanying documents, technical description |
46 | Annex D (informative) Symbols on marking |
47 | Annex AA (informative) Particular guidance and rationale AA.1 General guidance |
49 | AA.2 Rationale for particular clauses and subclauses |
58 | Annex BB (informative) Skin temperature at the cerebral tissue oximeter probe BB.1 Surface temperature limits BB.2 Literature review BB.3 Test methods |
60 | Annex CC (informative) Determination of accuracy CC.1 General CC.2 Accuracy, bias and precision CC.2.1 Definitions from other standards CC.2.1.1 Accuracy CC.2.1.2 Bias |
61 | CC.2.1.3 Precision CC.2.2 Effects of offset and linearity errors CC.2.3 Bias (see Figures CC.1 and CC.2) |
63 | CC.2.4 Precision CC.2.5 Accuracy |
64 | CC.2.6 Analysis |
65 | CC.2.7 Trend accuracy CC.2.8 Statistical Considerations |
66 | Annex DD (informative) Characteristics of a tissue haemoglobin phantom for the verification of the accuracy of cerebral tissue oximeter equipment DD.1 General |
67 | DD.2 Features of the tissue haemoglobin phantom DD.2.1 General |
68 | DD.2.2 Safety precautions regarding blood or blood components DD.2.3 Composition of the tissue haemoglobin phantom liquid |
69 | DD.2.4 Design of the tissue haemoglobin phantom setup DD.2.4.1 Liquid-probe interface DD.2.4.2 Container |
70 | DD.2.4.3 Probe arrangement DD.2.4.3.1 Immersed probe DD.2.4.3.2 Probe attached to turbid window |
71 | DD.2.5 Methods to change oxygenation |
72 | DD.2.6 Reference measurement for SphanO2 |
73 | DD.3 Procedures for verification of cerebral tissue oximeter equipment with the tissue haemoglobin phantom DD.3.1 Purpose of the verification DD.3.2 Test procedure of the verification |
74 | DD.4 Specifications of the tissue haemoglobin phantom DD.4.1 Target parameters of the tissue haemoglobin phantom |
75 | DD.4.2 Properties of the tissue haemoglobin phantom to be disclosed |
76 | Annex EE (informative) Guideline for evaluating and documenting StO2 accuracy in human subjects EE.1 General EE.2 Procedure for laboratory testing on healthy volunteers EE.2.1 Purpose of a controlled desaturation study EE.2.2 Scope of a controlled desaturation study |
77 | EE.2.3 Methods EE.2.3.1 Study population |
78 | EE.2.3.2 Apparatus EE.2.3.2.1 CO-oximeter for measuring SaO2, SjvO2 and procedures and supplies recommended by the CO-oximeter manufacturer. EE.2.3.2.2 Materials for arterial catheterization, jugular venous bulb catheter and blood sampling. EE.2.3.2.3 Means for recording StO2 values (device under test), which can be manual or automated. EE.2.3.2.4 Cerebral tissue oximeter equipment to be tested. See also EE.2.3.4 c). EE.2.3.2.5 Means for delivering a medical grade oxygen-nitrogen mixture of varying FiO2 levels to the subject (e.g. pre-mixed high-pressure cylinders or gas-mixing equipment). EE.2.3.3 Procedure |
80 | EE.2.3.4 Data analysis EE.3 Testing on patients EE.3.1 Procedure |
82 | Annex FF (informative) Functional testers for cerebral tissue oximeter equipment FF.1 General FF.2 What is a simulator? FF.3 What is a functional tester? |
83 | FF.4 Types of functional testers and their uses |
85 | Annex GG (informative) Concepts of ME equipment response time GG.1 General GG.2 Fidelity |
87 | GG.3 Effects of delays |
90 | Annex HH (normative) Data interface requirements HH.1 Background and purpose HH.2 Data definition |
93 | HH.3 Clinical context |
94 | Annex II (informative) Comparison of methods of performance evaluation II.1 General II.2 Rationale for multiple methods of accuracy performance verification II.3 Desire for improvement of methods for accuracy performance verification |
95 | II.4 Optimizing the methods of accuracy performance verification II.5 Comparing the methods of accuracy performance verification |
99 | Annex JJ (informative) Reference to the IMDRF essential principles and labelling guidances |
102 | Annex KK (informative) Reference to the essential principles |
105 | Annex LL (informative) Reference to the general safety and performance requirements |
108 | Annex MM (informative) Terminology — alphabetized index of defined terms |
112 | Bibliography |